TABLE 2.
Correlations between BATF2 protein expressions and clinical characteristics in NPC patients.
| Clinicopathological features | Total case size | BATF2 expression (+) | BATF2 expression (-) | χ2 value | P Value |
|---|---|---|---|---|---|
| Age (years) | 0.533 | 0.244 | |||
| >50 | 60 | 26 | 34 | ||
| ≤50 | 69 | 37 | 32 | ||
| Gender | 0.021 | 0.884 | |||
| Male | 99 | 48 | 51 | ||
| Female | 30 | 15 | 15 | ||
| Recurrence | 46.735 | 0.000 | |||
| Yes | 57 | 9 | 48 | ||
| No | 72 | 55 | 17 | ||
| Clinical stage | 4.225 | 0.040 | |||
| Stage I + II | 70 | 40 | 30 | ||
| Stage III + IV | 59 | 23 | 36 | ||
| Tumor size (cm) | 0.477 | 0.490 | |||
| ≥2 | 12 | 7 | 5 | ||
| <2 | 117 | 56 | 61 | ||
| Cervical lymph nodes | 1.355 | 0.244 | |||
| Yes | 96 | 44 | 52 | ||
| No | 33 | 19 | 14 |